Skip to main content

Prevalence of Type 1 Diabetes Steady in Youth, Adults

Medically reviewed by Carmen Pope, BPharm. Last updated on April 10, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, April 10, 2024 -- Nearly four in every 1,000 U.S. youths and five in every 1,000 U.S. adults reported having type 1 diabetes from 2019 through 2022, according to a research letter published online April 4 in the Journal of the American Medical Association.

Michael Fang, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues updated estimates of type 1 diabetes prevalence and characterized rates in population subgroups. The analysis included data from the 2019 to 2022 cycles of the National Health Interview Survey (110,283 adults and 30,708 youths).

The researchers found that among youths, the reported prevalence of type 1 diabetes was 3.5 per 1,000, with the highest rates seen among those aged 10 to 17 years (5.0), males (4.0), Hispanic youths (3.5), and non-Hispanic White youths (3.9). The reported prevalence in adults was 5.3 per 1,000 and was highest among those aged 45 to 64 years (6.1) and 65 years and older (5.3), non-Hispanic Black adults (4.8), and non-Hispanic White adults (5.9).

"These results are consistent with the U.S. Centers for Disease Control and Prevention's estimates for 2021," the authors write. "This study adds to existing research by providing more precise up-to-date national estimates and by characterizing differences across subgroups."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.